Suppr超能文献

美国老年透析患者中房颤发病率的变化趋势。

Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.

机构信息

Division of General Medical Disciplines, Stanford University School of Medicine, Palo Alto, CA 94304, USA.

出版信息

Circulation. 2012 Nov 6;126(19):2293-301. doi: 10.1161/CIRCULATIONAHA.112.099606. Epub 2012 Oct 2.

Abstract

BACKGROUND

One sixth of US dialysis patients 65 years of age have been diagnosed with atrial fibrillation/flutter (AF). Little is known, however, about the incidence of AF in this population.

METHODS AND RESULTS

We identified 258 605 older patients (≥67 years of age) with fee-for-service Medicare initiating dialysis in 1995 to 2007, who had not been diagnosed with AF within the previous 2 years. Patients were followed for newly diagnosed AF. Multivariable proportional hazard regression was used to examine temporal trends and associations of race and ethnicity with incident AF. We also studied temporal trends in the mortality and risk of ischemic stroke after new AF. Over 514 395 person-years of follow-up, 76 252 patients experienced incident AF for a crude AF incidence rate of 148/1000 person-years. Incidence of AF increased by 11% (95% confidence interval, 5-16) from 1995 to 2007. Compared with non-Hispanic whites, blacks (-30%), Asians (-19%), Native Americans (-42%), and Hispanics (-29%) all had lower rates of incident AF. Mortality after incident AF decreased by 22% from 1995 to 2008. Even more pronounced reductions were seen for incident ischemic stroke during these years.

CONCLUSIONS

The incidence of AF is high in older patients initiating dialysis in the United States and has been increasing over the 13 years of study. Mortality declined during that time but remained >50% during the first year after newly diagnosed AF. Because data on warfarin use were not available, we were unable to study whether trends toward better outcomes could be explained by higher rates of oral anticoagulation.

摘要

背景

在美国,1/6 的 65 岁以上透析患者被诊断患有心房颤动/扑动(AF)。然而,对于这一人群中 AF 的发病率知之甚少。

方法和结果

我们确定了 1995 年至 2007 年间 258605 名年龄在 67 岁以上、在过去 2 年内未被诊断出患有 AF 的接受自费医疗保险的老年患者(≥67 岁)。对患者进行新诊断的 AF 随访。多变量比例风险回归用于检查种族和民族与新发 AF 的时间趋势和关联。我们还研究了新诊断 AF 后死亡率和缺血性中风风险的时间趋势。在超过 514395 人年的随访中,76252 名患者发生新发 AF,粗发病率为 148/1000 人年。AF 的发病率从 1995 年到 2007 年增加了 11%(95%置信区间,5-16)。与非西班牙裔白人相比,黑人(-30%)、亚洲人(-19%)、美国原住民(-42%)和西班牙裔(-29%)新发 AF 的发生率均较低。新发 AF 后死亡率从 1995 年到 2008 年下降了 22%。在这几年中,新发缺血性中风的降幅更为显著。

结论

在美国开始透析的老年患者中,AF 的发病率很高,在研究的 13 年中一直在增加。在此期间,死亡率有所下降,但在新诊断为 AF 后的第一年仍超过 50%。由于没有关于华法林使用的数据,我们无法研究更好的预后趋势是否可以通过更高的口服抗凝剂使用率来解释。

相似文献

1
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.
Circulation. 2012 Nov 6;126(19):2293-301. doi: 10.1161/CIRCULATIONAHA.112.099606. Epub 2012 Oct 2.
2
Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.
Am J Kidney Dis. 2019 Mar;73(3):324-331. doi: 10.1053/j.ajkd.2018.09.011. Epub 2018 Nov 16.
4
Atrial fibrillation and risk of stroke in dialysis patients.
Ann Epidemiol. 2013 Mar;23(3):112-8. doi: 10.1016/j.annepidem.2012.12.011. Epub 2013 Jan 16.
6
Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Am J Kidney Dis. 2015 Oct;66(4):677-88. doi: 10.1053/j.ajkd.2015.05.019. Epub 2015 Jul 7.
7
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
Clin J Am Soc Nephrol. 2011 Nov;6(11):2662-8. doi: 10.2215/CJN.04550511. Epub 2011 Sep 29.
8
Incident atrial fibrillation among Asians, Hispanics, blacks, and whites.
Circulation. 2013 Dec 3;128(23):2470-7. doi: 10.1161/CIRCULATIONAHA.113.002449. Epub 2013 Oct 8.
10
Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.
Am J Cardiol. 2015 Jul 15;116(2):230-5. doi: 10.1016/j.amjcard.2015.04.012. Epub 2015 Apr 16.

引用本文的文献

3
Subclinical Atrial Fibrillation Screening in Dialytic Chronic Kidney Disease Patients Using Portable Device.
Arq Bras Cardiol. 2025 Mar;122(3):e20240450. doi: 10.36660/abc.20240450.
4
Anticoagulation Strategies for Atrial Fibrillation in CKD Stage G5 and Dialysis Patients: An Updated Scoping Review.
Rev Cardiovasc Med. 2025 Mar 5;26(3):26736. doi: 10.31083/RCM26736. eCollection 2025 Mar.
5
Brain natriuretic peptide is a biomarker of atrial fibrillation in hemodialysis patients.
Ren Fail. 2025 Dec;47(1):2463563. doi: 10.1080/0886022X.2025.2463563. Epub 2025 Feb 20.
7
Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients.
Int Urol Nephrol. 2025 Mar;57(3):897-906. doi: 10.1007/s11255-024-04260-w. Epub 2024 Oct 28.
9
Mid-Life Cardiorespiratory Fitness, Obesity, and Risk of Atrial Fibrillation: The Cooper Center Longitudinal Study.
JACC Adv. 2022 May 31;1(2):100040. doi: 10.1016/j.jacadv.2022.100040. eCollection 2022 Jun.
10
Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease.
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102350. doi: 10.1016/j.rpth.2024.102350. eCollection 2024 Feb.

本文引用的文献

1
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.
2
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.
JAMA. 2011 Nov 23;306(20):2248-54. doi: 10.1001/jama.2011.1615. Epub 2011 Nov 13.
4
Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
Circulation. 2011 Jun 28;123(25):2946-53. doi: 10.1161/CIRCULATIONAHA.111.020982. Epub 2011 Jun 6.
6
The increasing prevalence of atrial fibrillation among hemodialysis patients.
J Am Soc Nephrol. 2011 Feb;22(2):349-57. doi: 10.1681/ASN.2010050459. Epub 2011 Jan 13.
7
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.
Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15.
8
European ancestry as a risk factor for atrial fibrillation in African Americans.
Circulation. 2010 Nov 16;122(20):2009-15. doi: 10.1161/CIRCULATIONAHA.110.958306.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验